by Jordana Choucair | Aug 23, 2022 | Life Sciences
Pfizer and BioNTech have submitted their application to the Food and Drug Administration (FDA) for emergency use authorization of their updated COVID19 vaccine booster that specifically targets Omicron subvariants BA.4 and BA.5. If approved, the updated vaccine could...
by Jordana Choucair | Aug 23, 2022 | M&A
Third Horizon Strategies Founder and CEO David Smith shared his insights on Amazon’s recent acquisition of One Medical and if the deal has the potentially to materially disrupt health care delivery. Pointing to similar announcements in the late 2010s where big promise...
by Jordana Choucair | Aug 23, 2022 | Payers
A study published in JAMA Internal Medicine supports the connection between health and financial stability, showing that individuals with a higher number of chronic conditions have a higher chance of encountering financial hardship. The adjusted amount of medical debt...
by Jordana Choucair | Aug 23, 2022 | Public Health/Prevention
New data from the Centers for Disease Control and Prevention (CDC) show that life expectancy in all 50 states and Washington, D.C. declined from 2019 to 2020. The CDC primarily attributes the decline to the onset of the COVID-19 pandemic and “unintentional...
by Jordana Choucair | Aug 22, 2022 | Access & Coverage
The U.S. Department of Health and Human Services (HHS) released a report indicating that roughly 17.4 percent of Medicaid and Children’s Health Insurance Program (CHIP) enrollee would lose coverage with the expiration of the COVID-19 public health emergency....
by Jordana Choucair | Aug 22, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved Novavax’s COVID-19 vaccine for emergency use in adolescents, paving the way to expand eligibility for the fourth shot available in the U.S. The two-dose regimen utilizes protein-based technology previously leveraged in...
Recent Comments